全文获取类型
收费全文 | 16152篇 |
免费 | 1070篇 |
国内免费 | 212篇 |
专业分类
耳鼻咽喉 | 381篇 |
儿科学 | 230篇 |
妇产科学 | 305篇 |
基础医学 | 2733篇 |
口腔科学 | 312篇 |
临床医学 | 1306篇 |
内科学 | 3219篇 |
皮肤病学 | 479篇 |
神经病学 | 1226篇 |
特种医学 | 1143篇 |
外科学 | 2108篇 |
综合类 | 141篇 |
现状与发展 | 3篇 |
一般理论 | 10篇 |
预防医学 | 628篇 |
眼科学 | 446篇 |
药学 | 1272篇 |
中国医学 | 154篇 |
肿瘤学 | 1338篇 |
出版年
2023年 | 92篇 |
2022年 | 280篇 |
2021年 | 665篇 |
2020年 | 271篇 |
2019年 | 441篇 |
2018年 | 528篇 |
2017年 | 413篇 |
2016年 | 622篇 |
2015年 | 881篇 |
2014年 | 968篇 |
2013年 | 1098篇 |
2012年 | 1583篇 |
2011年 | 1436篇 |
2010年 | 868篇 |
2009年 | 736篇 |
2008年 | 901篇 |
2007年 | 943篇 |
2006年 | 782篇 |
2005年 | 635篇 |
2004年 | 528篇 |
2003年 | 478篇 |
2002年 | 389篇 |
2001年 | 305篇 |
2000年 | 247篇 |
1999年 | 188篇 |
1998年 | 121篇 |
1997年 | 102篇 |
1996年 | 70篇 |
1995年 | 62篇 |
1994年 | 55篇 |
1993年 | 65篇 |
1992年 | 44篇 |
1991年 | 47篇 |
1990年 | 48篇 |
1989年 | 71篇 |
1988年 | 48篇 |
1987年 | 55篇 |
1986年 | 32篇 |
1985年 | 22篇 |
1984年 | 19篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1981年 | 24篇 |
1980年 | 17篇 |
1979年 | 16篇 |
1978年 | 12篇 |
1977年 | 15篇 |
1976年 | 17篇 |
1975年 | 15篇 |
1941年 | 11篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
101.
Lee Lucy Eunju Pyo Jung Yoon Ahn Sung Soo Song Jason Jungsik Park Yong-Beom Lee Sang-Won 《International urology and nephrology》2021,53(8):1631-1638
International Urology and Nephrology - A systemic inflammation response index (SIRI) has been recently introduced as a tool for the assessment of the prognosis of several critical medical... 相似文献
102.
Jun Ho Kim Eunsun Oh Young Cheol Yoon Do Kyung Lee Sung-Sahn Lee Joon Ho Wang 《Arthroscopy》2021,37(1):209-221
103.
104.
Raoud Marayati Laura V. Bownes Colin H. Quinn Nikita Wadhwani Adele P. Williams Hooper R. Markert Venkatram Atigadda Jamie M. Aye Jerry E. Stewart Karina J. Yoon Elizabeth A. Beierle 《Journal of pediatric surgery》2021,56(6):1165-1173
IntroductionThe poor therapeutic efficacy seen with current treatments for neuroblastoma may be attributed to stem cell-like cancer cells (SCLCCs), a subpopulation of cancer cells associated with poor prognosis and disease recurrence. Retinoic acid (RA) is a differentiating agent used as maintenance therapy for high-risk neuroblastoma but nearly half of children treated with RA relapse. We hypothesized that 6-Methyl-UAB30 (6-Me), a second-generation rexinoid recently developed with a favorable toxicity profile compared to RA, would reduce cancer cell stemness in human neuroblastoma patient-derived xenografts (PDXs).MethodsCells from three neuroblastoma PDXs were treated with 6-Me and proliferation, viability, motility, and cell-cycle progression were assessed. CD133 expression, sphere formation, and mRNA abundance of stemness and differentiation markers were evaluated using flow cytometry, in vitro extreme limiting dilution analysis, and real-time PCR, respectively.ResultsTreatment with 6-Me decreased proliferation, viability, and motility, and induced cell-cycle arrest and differentiation in all three neuroblastoma PDXs. In addition, 6-Me treatment led to decreased CD133 expression, decreased sphere-forming ability, and decreased mRNA abundance of Oct4, Nanog, and Sox2, indicating decreased cancer cell stemness.Conclusions6-Me decreased oncogenicity and reduced cancer cell stemness of neuroblastoma PDXs, warranting further exploration of 6-Me as potential novel therapy for neuroblastoma. 相似文献
105.
Sara Kim Berik Rovgaliyev Jeong-Moo Lee Kwang-Woong Lee Suk Kyun Hong Jae-Hyung Cho Kyung Chul Yoon Nam-Joon Yi Kyung-Suk Suh 《Transplantation proceedings》2021,53(1):200-206
BackgroundSeveral studies have reported that solid organ transplant recipients have a high risk for malignant tumors because the suppressed immune system fails in preventing malignant transformations. De novo malignancy after transplantation is the most common cause of death in the late period after liver transplant (LT). This study investigated the clinical significance of de novo malignancy after LT, and it is the largest study based in Korea to report long-term follow-up results associated with de novo malignancy after LT.MethodsData of 1793 adults who underwent LT in Seoul National University Hospital were retrospectively collected, and medical charts and data from the Ministry of Public Administration and Security were reviewed to examine the causes of death and de novo malignancy status. The Fisher exact test and Kaplan-Meier survival analysis were used to analyze the data.ResultsOf the 1793 recipients, 27 died of de novo malignancies. Of 875 hepatocellular carcinoma (HCC) patients, 12 died, and of 918 non-HCC patients, 15 died. De novo malignancy was the main cause of death at 5 years after LT but was not in the initial 5 years. In Korea the most common cancers that developed after LT were gastric cancer (21.4%) and lymphoma (14.3%). De novo HCC in non-HCC cases was found in 2 patients.ConclusionDe novo malignancy is a key factor affecting long-term survival after LT. Therefore, regular screening and education are important for improving long-term survival and quality of life in these patients after LT. 相似文献
106.
107.
108.
Jong Jin Oh Sangchul Lee Ja Hyeon Ku Tae Gyun Kwon Tae-Hwan Kim Seung Hyun Jeon Sang Hyup Lee Jong Kil Nam Wan Seok Kim Byong Chang Jeong Ji Youl Lee Sung Hoo Hong Koon Ho Rha Woong Kyu Han Won Sik Ham Young Goo Lee Yong Seong Lee Sung Yul Park Young Eun Yoon Sung Gu Kang Seok Ho Kang Korean Robot Assisted Radical Cystectomy Study Group 《BJU international》2021,127(2):182-189
109.